NEWS
Free Institutional Consultancy Services
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Kellie Nance
National Cancer Institute - Bethesda / United States
Others
AD Scientific Index ID: 4399517
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Kellie Nance's MOST POPULAR ARTICLES
1-)
Modifications in an emergency: the role of N1-methylpseudouridine in COVID-19 vaccinesKD Nance, JL MeierACS Central Science 7 (5), 748-756, 20211212021
2-)
Dynamic RNA acetylation revealed by quantitative cross-evolutionary mappingA Sas-Chen, JM Thomas, D Matzov, M Taoka, KD Nance, R Nir, ...Nature 583 (7817), 638-643, 20201212020
3-)
A chemical signature for cytidine acetylation in RNAJM Thomas, CA Briney, KD Nance, JE Lopez, AL Thorpe, SD Fox, ...Journal of the American Chemical Society 140 (40), 12667-12670, 2018512018
4-)
Discovery of VU0467485/AZ13713945: An M4 PAM Evaluated as a Preclinical Candidate for the Treatment of SchizophreniaMR Wood, MJ Noetzel, BJ Melancon, MS Poslusney, KD Nance, ...ACS medicinal chemistry letters 8 (2), 233-238, 2017602017
5-)
A Novel M1 PAM VU0486846 Exerts Efficacy in Cognition Models without Displaying Agonist Activity or Cholinergic ToxicityJM Rook, JL Bertron, HP Cho, PM Garcia-Barrantes, SP Moran, ...ACS chemical neuroscience 9 (9), 2274-2285, 2018582018
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept